T1	Participants 141 153	FIT-AD trial
T2	Participants 67 86	Alzheimer's disease
T3	Participants 498 517	Alzheimer's disease
T4	Participants 890 963	community-dwelling older adults with mild-to-moderate Alzheimer's disease
T5	Participants 1819 1836	sample size of 90
